Sign In
Buy FATE
$2.22
-0.350 (-13.62%)
At Close: Jun 03, 2026
Oppenheimer Maintains Outperform on Fate Therapeutics, Lowers Price Target to $34
02:57pm, Monday, 06'th Apr 2020What Wedbush Is Watching in Biotechs Amid Coronavirus Crisis
02:39pm, Monday, 06'th Apr 2020
In a recent report from Wedbush Securities, the boutique brokerage firm recaps the COVID-19 impact on its coverage universe. Here, 24/7 Wall St. has picked out some of Wedbush’s top picks within the
Fate Therapeutics (FATE) Looks Good: Stock Adds 8.9% in Session
01:08pm, Monday, 06'th Apr 2020
Fate Therapeutics (FATE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Fate Therapeutics (FATE) Looks Good: Stock Adds 8.9% in Session
01:08pm, Monday, 06'th Apr 2020
Fate Therapeutics (FATE) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
Franklin Resources Inc. Has $34.52 Million Stock Position in Fate Therapeutics Inc (NASDAQ:FATE)
09:48am, Monday, 06'th Apr 2020
Franklin Resources Inc. reduced its stake in shares of Fate Therapeutics Inc (NASDAQ:FATE) by 23.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and E
Fate Therapeutics (FATE) Received its Third Buy in a Row
12:43am, Monday, 06'th Apr 2020
After SunTrust Robinson and Mizuho Securities gave Fate Therapeutics (NASDAQ: FATE) a Buy rating last month, the company received another Buy, this time
Fate Therapeutics (FATE) Received its Third Buy in a Row
12:42am, Monday, 06'th Apr 2020
After SunTrust Robinson and Mizuho Securities gave Fate Therapeutics (NASDAQ: FATE) a Buy rating last month, the company received another
Fate Therapeutics (NASDAQ:FATE) Sees Strong Trading Volume on Analyst Upgrade
05:12am, Sunday, 05'th Apr 2020
Fate Therapeutics Inc (NASDAQ:FATE) shares saw unusually-strong trading volume on Friday after Piper Sandler raised their price target on the stock. Approximately 3,951,016 shares were traded during m
Growth Investors: Industry Analysts Just Upgraded Their Fate Therapeutics, Inc. (NASDAQ:FATE) Revenue Forecasts By 13%
01:07pm, Saturday, 04'th Apr 2020
Fate Therapeutics, Inc. (NASDAQ:FATE) shareholders will have a reason to smile today, with the analysts making...
Need To Know: Analysts Are Much More Bullish On Fate Therapeutics, Inc. (NASDAQ:FATE) Revenues
12:59pm, Saturday, 04'th Apr 2020
Fate Therapeutics, Inc. (NASDAQ:FATE) shareholders will have a reason to smile today, with the analysts making...
Coronavirus Roundtable - Strains And Hopes In The Healthcare Sector
11:30am, Saturday, 04'th Apr 2020
The healthcare sector is on the front lines of treating, preventing, and ultimately solving the coronavirus issues. We discuss with our panelists how the sector
Raymond James & Associates Trims Position in Fate Therapeutics Inc (NASDAQ:FATE)
09:26am, Saturday, 04'th Apr 2020
Raymond James & Associates lessened its stake in shares of Fate Therapeutics Inc (NASDAQ:FATE) by 15.3% during the 4th quarter, according to the company in its most recent filing with the Securities &
7 Promising Biotech Stocks in a Postpandemic World
10:34pm, Friday, 03'rd Apr 2020
The life-sciences sector will emerge as a winner from the current crisis, says Eli Casdin, founder of Casdin Capital. Why Chinese biotechs look appealing
Fate Inks $100M Deal With Janssen for Stem Cell-Derived Cancer Therapies
10:07pm, Friday, 03'rd Apr 2020
Fate Therapeutics has signed an agreement with Janssen Biotech to develop new cancer cell therapies that are derived from stem cells and landed $100
Mid-Afternoon Market Update: Dow Falls 500 Points; electroCore Shares Spike Higher
06:24pm, Friday, 03'rd Apr 2020
Toward the end of trading Friday, the Dow traded down 2.34% to 20913.26 while the NASDAQ fell 2.48% to 7301.42. The S&P also fell, dropping 2.53% to 2,462.91.
The U.S. is now...
